NCT06521866 2025-03-14
Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer
Fudan University
Phase 2 Recruiting
Clinical Trials
3 trialsNCT05406206 2022-06-06
Hepatic Arterial Infusion Chemotherapy With Fruquintinib for Colorectal Cancer Liver Metastases As Third-line Therapy
Peking University Cancer Hospital & Institute
Phase 2 Unknown
NCT04582981 2021-10-26
Fruquintinib and Raltitrexed Versus Fruquintinib Monotherapy in Advanced Colorectal Cancer
Fudan University
Phase 2 Unknown